$PGEN
PRECIGEN, INC. Stock $pgen

$pgen Overview Financials Valuation SEC Filings Company Website

2024 Q4 Form 10-Q Financial Statement

#000135609024000026 Filed on November 14, 2024

Income Statement

Concept	2024 Q4	2024 Q3
Revenue		$953.0K
YoY Change		-30.94%
Cost Of Revenue		$1.009M
YoY Change		-34.48%
Gross Profit		-$56.00K
YoY Change		-65.0%
Gross Profit Margin		-5.88%
Selling, General & Admin		$9.836M
YoY Change		6.91%
% of Gross Profit
Research & Development		$11.37M
YoY Change		-1.81%
% of Gross Profit
Depreciation & Amortization		$356.0K
YoY Change		-17.97%
% of Gross Profit
Operating Expenses		$21.21M
YoY Change		2.05%
Operating Profit		-$21.26M
YoY Change		1.54%
Interest Expense		$281.0K
YoY Change		-67.33%
% of Operating Profit
Other Income/Expense, Net		-$2.985M
YoY Change		-1166.07%
Pretax Income		-$23.97M
YoY Change		21.03%
Income Tax		$12.00K
% Of Pretax Income
Net Earnings		-$23.98M
YoY Change		21.13%
Net Earnings / Revenue		-2516.05%
Basic Earnings Per Share		-$0.09
Diluted Earnings Per Share		-$0.09
COMMON SHARES
Basic Shares Outstanding	292.9M shares	252.8M shares
Diluted Shares Outstanding		275.9M shares

Balance Sheet

Concept	2024 Q4	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments		$28.63M
YoY Change		-61.2%
Cash & Equivalents		$24.73M
Short-Term Investments		$3.906M
Other Short-Term Assets		$5.153M
YoY Change		1.04%
Inventory
Prepaid Expenses
Receivables		$479.0K
Other Receivables		$250.0K
Total Short-Term Assets		$34.51M
YoY Change		-62.88%
LONG-TERM ASSETS
Property, Plant & Equipment		$13.54M
YoY Change		90.27%
Goodwill		$24.92M
YoY Change		-32.46%
Intangibles		$4.773M
YoY Change		-88.19%
Long-Term Investments
YoY Change
Other Assets		$425.0K
YoY Change		-46.68%
Total Long-Term Assets		$48.96M
YoY Change		-49.89%
TOTAL ASSETS
Total Short-Term Assets		$34.51M
Total Long-Term Assets		$48.96M
Total Assets		$83.47M
YoY Change		-56.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable		$4.320M
YoY Change		83.75%
Accrued Expenses		$16.49M
YoY Change		-45.04%
Deferred Revenue		$407.0K
YoY Change		-20.04%
Short-Term Debt		$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities		$21.22M
YoY Change		-35.46%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00
YoY Change
Other Long-Term Liabilities		$6.793M
YoY Change		-15.09%
Total Long-Term Liabilities		$6.793M
YoY Change		-15.09%
TOTAL LIABILITIES
Total Short-Term Liabilities		$21.22M
Total Long-Term Liabilities		$6.793M
Total Liabilities		$28.10M
YoY Change		-34.67%
SHAREHOLDERS EQUITY
Retained Earnings		-$2.071B
YoY Change		7.23%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity		$55.38M
YoY Change
Total Liabilities & Shareholders Equity		$83.47M
YoY Change		-56.22%

Cashflow Statement

Concept	2024 Q4	2024 Q3
OPERATING ACTIVITIES
Net Income		-$23.98M
YoY Change		21.13%
Depreciation, Depletion And Amortization		$356.0K
YoY Change		-17.97%
Cash From Operating Activities		-$22.73M
YoY Change		33.72%
INVESTING ACTIVITIES
Capital Expenditures		$882.0K
YoY Change		283.48%
Acquisitions
YoY Change
Other Investing Activities		$6.535M
YoY Change		-39.27%
Cash From Investing Activities		$5.653M
YoY Change		-46.32%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities		32.13M
YoY Change
NET CHANGE
Cash From Operating Activities		-22.73M
Cash From Investing Activities		5.653M
Cash From Financing Activities		32.13M
Net Change In Cash		15.05M
YoY Change		-332.57%
FREE CASH FLOW
Cash From Operating Activities		-$22.73M
Capital Expenditures		$882.0K
Free Cash Flow		-$23.61M
YoY Change		37.06%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	dei	Entity Central Index Key EntityCentralIndexKey	0001356090
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Type DocumentType	10-Q
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-09-30
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	001-36042
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	VA
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	26-0084895
	dei	Entity Address Address Line1 EntityAddressAddressLine1	20374 Seneca Meadows Parkway
	dei	Entity Address City Or Town EntityAddressCityOrTown	Germantown,
	dei	Entity Address State Or Province EntityAddressStateOrProvince	MD
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	20876
	dei	City Area Code CityAreaCode	301
	dei	Local Phone Number LocalPhoneNumber	556-9900
	dei	Security12b Title Security12bTitle	Common Stock, no par value
	dei	Trading Symbol TradingSymbol	PGEN
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-23978000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-19795000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	32179000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-25000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	16877000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7848000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48596000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24725000	usd
	us-gaap	Interest Paid Net InterestPaidNet	7000	usd
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	292869097	shares
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7578000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62848000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	55376000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62848000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-73000	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	60000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	6606000	usd
	pgen	Shares Issued During Period Value Issued For Services SharesIssuedDuringPeriodValueIssuedForServices	553000	usd
	pgen	Shares Issued During Period Value Issued For Services SharesIssuedDuringPeriodValueIssuedForServices	545000	usd
	dei	Amendment Flag AmendmentFlag	false
	dei	Entity Registrant Name EntityRegistrantName	PRECIGEN, INC.
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24725000	usd
CY2024Q3	us-gaap	Short Term Investments ShortTermInvestments	3906000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	55277000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	184000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	479000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	902000	usd
CY2024Q3	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	250000	usd
CY2023Q4	us-gaap	Other Receivables Net Current OtherReceivablesNetCurrent	673000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5153000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	4325000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	34513000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	68755000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13538000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7111000	usd
CY2024Q3	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	4773000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	40701000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	24918000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	26612000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	5307000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	7097000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	425000	usd
CY2024Q3	us-gaap	Assets Assets	83474000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	4320000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1726000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	6612000	usd
CY2023Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8250000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	5676000	usd
CY2024Q3	pgen	Settlement And Indemnification Accruals Current SettlementAndIndemnificationAccrualsCurrent	3213000	usd
CY2023Q4	pgen	Settlement And Indemnification Accruals Current SettlementAndIndemnificationAccrualsCurrent	5075000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	407000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	509000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	988000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1202000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	21216000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	22985000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2032000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1818000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	5895000	usd
CY2024Q3	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	89000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	1847000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	28098000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	32545000	usd
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2024Q3	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	292869097	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	256398527	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	292869097	shares
CY2023Q4	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2126342000	usd
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	2084916000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2070979000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-1964471000	usd
CY2024Q3	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	13000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-1947000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	55376000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	118498000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	83474000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	151043000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4761000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-19795000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-106508000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62848000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.08
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.08
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.41
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.41
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.26
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.26
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	275881170	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	248520724	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	248520724	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	259254775	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	259254775	shares
CY2024Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	29000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	123000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	44000	usd
	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Net Of Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax	614000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-22000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-1166000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-999000	usd
	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Arising During Period Net Of Tax OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationGainLossArisingDuringPeriodNetOfTax	-687000	usd
CY2023Q4	us-gaap	Assets Assets	151043000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	6223000	usd
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	248919096	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	243075262	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	243075262	shares
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-2915000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	767000	usd
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	400000000	shares
CY2024Q3	us-gaap	Common Stock Value Outstanding CommonStockValueOutstanding	0	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-23978000	usd
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	275881170	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	243075262	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	243075262	shares
	us-gaap	Net Income Loss NetIncomeLoss	-106508000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-2915000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-2915000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21056000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20838000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-104548000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-62921000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	43170000	usd
CY2024Q3	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	294000	usd
CY2024Q3	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	0	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30882000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-23978000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	55376000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	166210000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2306000	usd
CY2023Q3	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	0	usd
CY2023Q3	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-19795000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1043000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	147678000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	118498000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6606000	usd
	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	346000	usd
	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	3039000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30882000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-106508000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-2915000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-955000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	126259000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7626000	usd
	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	0	usd
	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	3361000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	545000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	72808000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	147678000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-106508000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62848000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3865000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	5054000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	0	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-21056000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-20838000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-104548000	usd
	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-62921000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	43170000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2061000	usd
CY2024Q3	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	294000	usd
CY2024Q3	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	0	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	25000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	30882000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-23978000	usd
CY2024Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	7000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	166210000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2306000	usd
CY2023Q3	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	0	usd
CY2023Q3	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	0	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-19795000	usd
CY2023Q3	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-1043000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	147678000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	118498000	usd
	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	346000	usd
	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	3039000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	553000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-106508000	usd
	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	-2915000	usd
	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-955000	usd
	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7626000	usd
	pgen	Stock Issued During Period Value Restricted Stock Awards Vested And Stock Options Exercised StockIssuedDuringPeriodValueRestrictedStockAwardsVestedAndStockOptionsExercised	0	usd
	pgen	Stock Issued During The Period Value Accrued Compensation StockIssuedDuringThePeriodValueAccruedCompensation	3361000	usd
	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	545000	usd
	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	72808000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	147678000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-62848000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	3865000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	68000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1630000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	32915000	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	usd
	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	-2915000	usd
	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	0	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	732000	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1294000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	7626000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	60000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-126000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-423000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-431000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	267000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	2000	usd
	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	68000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1630000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	32915000	usd
	us-gaap	Other Asset Impairment Charges OtherAssetImpairmentCharges	0	usd
	us-gaap	Disposal Group Including Discontinued Operation Foreign Currency Translation Gains Losses DisposalGroupIncludingDiscontinuedOperationForeignCurrencyTranslationGainsLosses	0	usd
	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1294000	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	0	usd
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	60000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1706000	usd
	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-126000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-3000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-423000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	10000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	-431000	usd
	us-gaap	Increase Decrease In Other Receivables IncreaseDecreaseInOtherReceivables	267000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	836000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	62000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-73000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-83000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	2337000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1759000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1338000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	3620000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1422000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1550000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	112000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	484000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-60000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	80000	usd
	pgen	Increase Decrease Settlement And Identification Accruals IncreaseDecreaseSettlementAndIdentificationAccruals	-1862000	usd
	pgen	Increase Decrease Settlement And Identification Accruals IncreaseDecreaseSettlementAndIdentificationAccruals	-675000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-59930000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-51164000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	74845000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	153698000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	126994000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	137748000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7556000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	491000	usd
	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	60000	usd
	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	61000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44653000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-16380000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31833000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	72808000	usd
	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	120000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	43219000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	346000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29589000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-306000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-38261000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10335000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	836000	usd
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	62000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-73000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-83000	usd
	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-1759000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	1338000	usd
	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	3620000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1422000	usd
	us-gaap	Increase Decrease In Other Accrued Liabilities IncreaseDecreaseInOtherAccruedLiabilities	-1550000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	112000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	484000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	-60000	usd
	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	80000	usd
	pgen	Increase Decrease Settlement And Identification Accruals IncreaseDecreaseSettlementAndIdentificationAccruals	-1862000	usd
	pgen	Increase Decrease Settlement And Identification Accruals IncreaseDecreaseSettlementAndIdentificationAccruals	-675000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-59930000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-51164000	usd
	us-gaap	Payments To Acquire Investments PaymentsToAcquireInvestments	153698000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	126994000	usd
	us-gaap	Proceeds From Sale And Maturity Of Available For Sale Securities ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities	137748000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	7556000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	491000	usd
	us-gaap	Proceeds From Sale Of Other Assets Investing Activities ProceedsFromSaleOfOtherAssetsInvestingActivities	60000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	44653000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	72808000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	0	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	43219000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	0	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	29589000	usd
	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-306000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-38261000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10335000	usd
	us-gaap	Interest Paid Net InterestPaidNet	1159000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	4000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	pgen	Accrued Compensation Paid In Equity Awards AccruedCompensationPaidInEquityAwards	3039000	usd
	pgen	Accrued Compensation Paid In Equity Awards AccruedCompensationPaidInEquityAwards	3361000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	733000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	772000	usd
	pgen	Sale Of Assets Included In Accounts Receivable SaleOfAssetsIncludedInAccountsReceivable	0	usd
	pgen	Sale Of Assets Included In Accounts Receivable SaleOfAssetsIncludedInAccountsReceivable	16000	usd
	pgen	Issuance Costs Included In Accounts Payable And Other Accrued Liabilities IssuanceCostsIncludedInAccountsPayableAndOtherAccruedLiabilities	951000	usd
	pgen	Issuance Costs Included In Accounts Payable And Other Accrued Liabilities IssuanceCostsIncludedInAccountsPayableAndOtherAccruedLiabilities	0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7578000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	270000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24725000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7848000	usd
CY2024Q3	pgen	Number Of Wholly Owned Operating Subsidiaries NumberOfWhollyOwnedOperatingSubsidiaries	2	subsidiary
CY2024Q3	pgen	Workforce Focus Of Potential Commercialization Percentage WorkforceFocusOfPotentialCommercializationPercentage	0.20
	us-gaap	Interest Paid Net InterestPaidNet	1159000	usd
	us-gaap	Income Taxes Paid IncomeTaxesPaid	0	usd
	pgen	Accrued Compensation Paid In Equity Awards AccruedCompensationPaidInEquityAwards	3039000	usd
	pgen	Accrued Compensation Paid In Equity Awards AccruedCompensationPaidInEquityAwards	3361000	usd
	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	733000	usd
	pgen	Sale Of Assets Included In Accounts Receivable SaleOfAssetsIncludedInAccountsReceivable	0	usd
	pgen	Sale Of Assets Included In Accounts Receivable SaleOfAssetsIncludedInAccountsReceivable	16000	usd
	pgen	Issuance Costs Included In Accounts Payable And Other Accrued Liabilities IssuanceCostsIncludedInAccountsPayableAndOtherAccruedLiabilities	951000	usd
	pgen	Issuance Costs Included In Accounts Payable And Other Accrued Liabilities IssuanceCostsIncludedInAccountsPayableAndOtherAccruedLiabilities	0	usd
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	24725000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7578000	usd
CY2024Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	0	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	270000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	24725000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	7848000	usd
CY2024Q3	pgen	Number Of Wholly Owned Operating Subsidiaries NumberOfWhollyOwnedOperatingSubsidiaries	2	subsidiary
CY2024Q3	pgen	Workforce Focus Of Potential Commercialization Percentage WorkforceFocusOfPotentialCommercializationPercentage	0.20
	us-gaap	Net Income Loss NetIncomeLoss	-106508000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-59930000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2070979000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	30882000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	28631000	usd
CY2024Q3	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	7382000	usd
CY2023Q4	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	17800000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-106508000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-59930000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2070979000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	30882000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	28631000	usd
CY2024Q3	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	7382000	usd
CY2023Q4	pgen	Research And Development Commitments Not Yet Incurred ResearchAndDevelopmentCommitmentsNotYetIncurred	17800000	usd
	pgen	Research And Development Commitments Cancellation Terms Required Written Notice Period Prior To Desired Termination Date ResearchAndDevelopmentCommitmentsCancellationTermsRequiredWrittenNoticePeriodPriorToDesiredTerminationDate	P60D
	pgen	Highly Liquid Investment Maximum Maturity Period HighlyLiquidInvestmentMaximumMaturityPeriod	P3M
	pgen	Highly Liquid Investment Maximum Maturity Period HighlyLiquidInvestmentMaximumMaturityPeriod	P3M
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30661877	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22912874	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	30661877	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	22912874	shares
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></div>
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2439000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2327000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	407000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2032000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2439000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2327000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	407000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	509000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	2032000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1818000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2439000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2327000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3906000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	3906000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	55310000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	103000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	136000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	55277000	usd
CY2024Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3906000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	55277000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Noncurrent ContractWithCustomerLiabilityNoncurrent	1818000	usd
CY2024Q3	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	2439000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	3893000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	13000	usd
CY2024Q3	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	0	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	3906000	usd
CY2024Q3	us-gaap	Available For Sale Securities Debt Maturities Next Rolling Twelve Months Fair Value AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue	3906000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	55310000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	103000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	136000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	55277000	usd
CY2024Q3	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	3906000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	55277000	usd
CY2024Q3	us-gaap	Land And Land Improvements LandAndLandImprovements	164000	usd
CY2023Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	164000	usd
CY2024Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2629000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2629000	usd
CY2024Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	364000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	530000	usd
CY2024Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	16773000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18576000	usd
CY2024Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4475000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4380000	usd
CY2024Q3	pgen	Breeding And Production Animals Gross BreedingAndProductionAnimalsGross	92000	usd
CY2023Q4	pgen	Breeding And Production Animals Gross BreedingAndProductionAnimalsGross	79000	usd
CY2024Q3	pgen	Computer Hardware And Software ComputerHardwareAndSoftware	3190000	usd
CY2023Q4	pgen	Computer Hardware And Software ComputerHardwareAndSoftware	3459000	usd
CY2024Q3	us-gaap	Land And Land Improvements LandAndLandImprovements	164000	usd
CY2023Q4	us-gaap	Land And Land Improvements LandAndLandImprovements	164000	usd
CY2024Q3	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2629000	usd
CY2023Q4	us-gaap	Buildings And Improvements Gross BuildingsAndImprovementsGross	2629000	usd
CY2024Q3	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	364000	usd
CY2023Q4	us-gaap	Furniture And Fixtures Gross FurnitureAndFixturesGross	530000	usd
CY2024Q3	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	16773000	usd
CY2023Q4	us-gaap	Machinery And Equipment Gross MachineryAndEquipmentGross	18576000	usd
CY2024Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4475000	usd
CY2023Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	4380000	usd
CY2024Q3	pgen	Breeding And Production Animals Gross BreedingAndProductionAnimalsGross	92000	usd
CY2023Q4	pgen	Breeding And Production Animals Gross BreedingAndProductionAnimalsGross	79000	usd
CY2024Q3	pgen	Computer Hardware And Software ComputerHardwareAndSoftware	3190000	usd
CY2023Q4	pgen	Computer Hardware And Software ComputerHardwareAndSoftware	3459000	usd
CY2024Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	8382000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1577000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	36069000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31394000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22531000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24283000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13538000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7111000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	356000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	434000	usd
	us-gaap	Depreciation Depreciation	1124000	usd
	us-gaap	Depreciation Depreciation	1415000	usd
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	110000	usd
CY2024Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	488000	usd
CY2024Q3	us-gaap	Construction In Progress Gross ConstructionInProgressGross	8382000	usd
CY2023Q4	us-gaap	Construction In Progress Gross ConstructionInProgressGross	1577000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	31394000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	22531000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	24283000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	13538000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	7111000	usd
CY2024Q3	us-gaap	Depreciation Depreciation	356000	usd
CY2023Q3	us-gaap	Depreciation Depreciation	434000	usd
	us-gaap	Depreciation Depreciation	1124000	usd
	us-gaap	Depreciation Depreciation	1415000	usd
CY2024Q1	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	110000	usd
CY2024Q2	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	488000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	26612000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1630000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-64000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	24918000	usd
CY2024Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	26503000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	24873000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	32317000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	318000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1217000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2741000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3639000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1706000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	26612000	usd
	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1630000	usd
	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-64000	usd
CY2024Q3	us-gaap	Goodwill Goodwill	24918000	usd
CY2024Q3	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	26503000	usd
CY2023Q4	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	24873000	usd
CY2024Q2	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	1630000	usd
CY2024Q2	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	32317000	usd
CY2024Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	318000	usd
CY2023Q3	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1217000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	2741000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3639000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	12000	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-6000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-1706000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-126000	usd
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	43962640	shares
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	72808000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-126000	usd
CY2023Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	72808000	usd
CY2024Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	39878939	shares
CY2024Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	30882000	usd
CY2024Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	39878939	shares
CY2018Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	7479431	shares
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2061000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2306000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6606000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7626000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	22057340	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	6.90
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y1M13D
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7230174	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.41
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	265448	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1027459	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.82
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1136787	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	16.74
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	26857820	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.66
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M7D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15508975	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.91
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y14D
CY2023Q1	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	43962640	shares
CY2024Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	39878939	shares
CY2024Q3	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	30882000	usd
CY2024Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	39878939	shares
CY2018Q3	us-gaap	Stock Issued During Period Shares Other StockIssuedDuringPeriodSharesOther	7479431	shares
CY2024Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2061000	usd
CY2023Q3	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2306000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6606000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7626000	usd
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	7230174	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	1.41
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	265448	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.30
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1027459	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	1.82
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	1136787	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	9.66
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P7Y3M7D
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	15508975	shares
CY2024Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	7.91
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P6Y14D
	pgen	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P1Y
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	337000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	621000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1555000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1853000	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	46000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	41000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	92000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	89000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	276000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	295000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	440000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	721000	usd
	us-gaap	Lease Cost LeaseCost	1877000	usd
	us-gaap	Lease Cost LeaseCost	2189000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	414000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1556000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1433000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1285000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1260000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1295000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	553000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7796000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2047000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5749000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	988000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4761000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5749000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y11M26D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M20D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.116
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.112
	us-gaap	Operating Lease Payments OperatingLeasePayments	1903000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1769000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	572000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	399000	usd
	pgen	Lessee Operating Lease Termination Period LesseeOperatingLeaseTerminationPeriod	P1Y
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	337000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	621000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1555000	usd
	us-gaap	Operating Lease Cost OperatingLeaseCost	1853000	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	11000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	46000	usd
	us-gaap	Short Term Lease Cost ShortTermLeaseCost	41000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	92000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	89000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	276000	usd
	us-gaap	Variable Lease Cost VariableLeaseCost	295000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	440000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	721000	usd
	us-gaap	Lease Cost LeaseCost	1877000	usd
	us-gaap	Lease Cost LeaseCost	2189000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	414000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1556000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	1433000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	1285000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	1260000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	1295000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	553000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	7796000	usd
CY2024Q3	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	2047000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5749000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	988000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	4761000	usd
CY2024Q3	us-gaap	Operating Lease Liability OperatingLeaseLiability	5749000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y11M26D
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P5Y4M20D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.116
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.112
	us-gaap	Operating Lease Payments OperatingLeasePayments	1903000	usd
	us-gaap	Operating Lease Payments OperatingLeasePayments	1769000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	572000	usd
	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	399000	usd
CY2024Q3	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	0	usd
CY2023Q4	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	0	usd
CY2024Q3	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	0	usd
CY2023Q4	us-gaap	Insurance Settlements Receivable InsuranceSettlementsReceivable	0	usd
CY2024Q3	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-19394000	usd
CY2023Q3	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-16901000	usd
	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-71471000	usd
	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-55460000	usd
CY2024Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-2915000	usd
CY2023Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-2915000	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23966000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19801000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-108214000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-62974000	usd
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-19394000	usd
CY2023Q3	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-16901000	usd
	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-71471000	usd
	pgen	Net Income Loss Attributable To Parent Adjusted Ebitda Including Cash Paid For Capital Expenditures And Investments In Affiliates NetIncomeLossAttributableToParentAdjustedEBITDAIncludingCashPaidForCapitalExpendituresAndInvestmentsInAffiliates	-55460000	usd
CY2024Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-2915000	usd
CY2023Q3	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	0	usd
	us-gaap	Deconsolidation Gain Or Loss Amount DeconsolidationGainOrLossAmount	-2915000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-23966000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-19801000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-108214000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-62974000	usd
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001356090-24-000026-index-headers.html	Edgar Link	pending
0001356090-24-000026-index.html	Edgar Link	pending
0001356090-24-000026.txt	Edgar Link	pending
0001356090-24-000026-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
pgen-20240930.htm	Edgar Link	pending
pgen-20240930.xsd	Edgar Link	pending
pgen-20240930x10qxexx101.htm	Edgar Link	pending
pgen-20240930x10qxexx101001.jpg	Edgar Link	pending
pgen-20240930x10qxexx101002.jpg	Edgar Link	pending
pgen-20240930x10qxexx101003.jpg	Edgar Link	pending
pgen-20240930x10qxexx101004.jpg	Edgar Link	pending
pgen-20240930x10qxexx101005.jpg	Edgar Link	pending
pgen-20240930x10qxexx101006.jpg	Edgar Link	pending
pgen-20240930xexx311.htm	Edgar Link	pending
pgen-20240930xexx312.htm	Edgar Link	pending
pgen-20240930xexx321.htm	Edgar Link	pending
pgen-20240930xexx322.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
pgen-20240930_cal.xml	Edgar Link	unprocessable
pgen-20240930_def.xml	Edgar Link	unprocessable
pgen-20240930_pre.xml	Edgar Link	unprocessable
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
pgen-20240930_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
pgen-20240930_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PGEN
PRECIGEN, INC. Stock $pgen

2024 Q4 Form 10-Q Financial Statement

#000135609024000026 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGEN PRECIGEN, INC. Stock $pgen

2024 Q4 Form 10-Q Financial Statement

#000135609024000026 Filed on November 14, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PGEN
PRECIGEN, INC. Stock $pgen